STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1

World Journal of Gastroenterology : WJG
Toufeng JinKeijiro Araki

Abstract

To estimate whether STI571 inhibits the expression of vascular endothelial growth factor (VEGF) in the gastrointestinal stromal tumor (GIST) cells. We used GIST cell line, GIST-T1. It has a heterogenic 57-bp deletion in exon 11 to produce a mutated c-KIT, which results in constitutive activation of c-KIT. Cells were treated with/without STI571 or stem cell factor (SCF). Transcription and expression of VEGF were determined by RT-PCR and flow cytometry or Western blotting, respectively. Activated c-KIT was estimated by immunoprecipitation analysis. Cell viability was determined by MTT assay. Activation of c-KIT was inhibited by STI571 treatment. VEGF was suppressed at both the transcriptional and translational levels in a temporal and dose-dependent manner by STI571. SCF upregulated the expression of VEGF and it was inhibited by STI571. STI571 also reduced the cell viability of the GIST-T1 cells, as determined by MTT assay. Activation of c-KIT in the GIST-T1 regulated the expression of VEGF and it was inhibited by STI571. STI571 has antitumor effects on the GIST cells with respect to not only the inhibition of cell growth, but also the suppression of VEGF expression.

References

Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·B J LongleyY Ma
Jun 11, 1999·The American Journal of Pathology·Q TianC A Moskaluk
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A J KnoxL Pang
Jan 24, 2002·Cancer Letters·Kentaro NakayamaYuji Takebayashi
May 11, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Takahiro TaguchiKazunari Yuri
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón

❮ Previous
Next ❯

Citations

Nov 20, 2015·Frontiers in Oncology·Monika Ehnman, Olle Larsson
Aug 29, 2020·PPAR Research·Siyue DuKay-Dietrich Wagner
Mar 6, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Masakazu ImamuraMasazumi Tsuneyoshi
Dec 11, 2007·Virchows Archiv : an International Journal of Pathology·Rosario S RiveraNoriyuki Nagai
Dec 13, 2006·Expert Opinion on Investigational Drugs·Alex KiselyovSergey E Tkachenko
Jun 11, 2011·Clinical and Experimental Medicine·Tian-bao WangWen-guang Dong
Feb 19, 2009·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·F BergerM F Reiser
Aug 14, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bilge CanBedri Kandemir
Jul 2, 2009·Reproduction : the Official Journal of the Society for the Study of Fertility·Sridurga Mithraprabhu, Kate L Loveland
May 29, 2013·Acta Oncologica·Mona-Elisabeth RevheimTherese Seierstad
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C McAuliffeJonathan C Trent

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.